CG Oncology (formerly Cold Genesys) is a clinical-stage biopharmaceutical company focused on the research, acquisition, and development of oncolytic immunotherapies to combat cancer. The Company offers CG0070, a proprietary agent, which has the potential to deliver safe and effective cancer care alone and in combination with other immunotherapies.
|HQ||Irvine, CA, US||Map|
|Employees (est.) (Sept 2021)||25||(+5%)|
CG Oncology total Funding
CG Oncology latest funding size
Time since last funding
|9 months ago|
CG Oncology investors
|WI Harper Group, Ally Bridge Group, ORI Healthcare Fund, Whitesun Healthcare Ventures, Song Hong Fang, Kissei Pharmaceutical, Camford Capital, Perseverance Capital Management|
CG Oncology has 115 Twitter Followers. The number of followers has decreased 0.3% month over month and increased 8.2% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was CG Oncology founded?
CG Oncology was founded in 2010.
Who are CG Oncology key executives?
CG Oncology's key executives are Arthur Kuan and Paola Grandi.
How many employees does CG Oncology have?
CG Oncology has 25 employees.
Who are CG Oncology competitors?
Competitors of CG Oncology include Jiangsu Hansoh Pharmaceutical Group, PLIVA and Takeda Oncology.
Where is CG Oncology headquarters?
CG Oncology headquarters is located at 400 Spectrum Center Dr Suite 2040, Irvine.
Where are CG Oncology offices?
CG Oncology has an office in Irvine.
How many offices does CG Oncology have?
CG Oncology has 1 office.
Receive alerts for 300+ data fields across thousands of companies